These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 20836123)
1. Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague-Dawley rats. Wise LD; Pauley CJ; Michael B; Wolf JJ Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):376-81. PubMed ID: 20836123 [TBL] [Abstract][Full Text] [Related]
2. Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats. Wise LD; Wolf JJ; Kaplanski CV; Pauley CJ; Ledwith BJ Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):561-72. PubMed ID: 19025783 [TBL] [Abstract][Full Text] [Related]
3. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. Giuliano AR; Lazcano-Ponce E; Villa L; Nolan T; Marchant C; Radley D; Golm G; McCarroll K; Yu J; Esser MT; Vuocolo SC; Barr E J Infect Dis; 2007 Oct; 196(8):1153-62. PubMed ID: 17955433 [TBL] [Abstract][Full Text] [Related]
4. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age. Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980 [TBL] [Abstract][Full Text] [Related]
5. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. Villa LL Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241 [TBL] [Abstract][Full Text] [Related]
6. Prevention strategies against the human papillomavirus: the effectiveness of vaccination. Stanley M Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013 [TBL] [Abstract][Full Text] [Related]
7. Correlating immunity with protection for HPV infection. Frazer I Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240 [TBL] [Abstract][Full Text] [Related]
8. Reproductive evaluation of male beagles and the safety of ivermectin. Daurio CP; Gilman MR; Pulliam JD; Seward RL Am J Vet Res; 1987 Dec; 48(12):1755-60. PubMed ID: 3434921 [TBL] [Abstract][Full Text] [Related]
10. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece). Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the intramuscular administration of Cervarix™ vaccine on fertility, pre- and post-natal development in rats. Segal L; Wilby OK; Willoughby CR; Veenstra S; Deschamps M Reprod Toxicol; 2011 Jan; 31(1):111-20. PubMed ID: 20851759 [TBL] [Abstract][Full Text] [Related]
12. The prophylactic role for the human papillomavirus quadrivalent vaccine in males. Yancey AM; Pitlick JM; Forinash AB Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891 [TBL] [Abstract][Full Text] [Related]
13. Measuring serum antibody to human papillomavirus following infection or vaccination. Frazer IH Gynecol Oncol; 2010 Jun; 118(1 Suppl):S8-11. PubMed ID: 20494221 [TBL] [Abstract][Full Text] [Related]
15. GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side. Shi L; Sings HL; Bryan JT; Wang B; Wang Y; Mach H; Kosinski M; Washabaugh MW; Sitrin R; Barr E Clin Pharmacol Ther; 2007 Feb; 81(2):259-64. PubMed ID: 17259949 [TBL] [Abstract][Full Text] [Related]
16. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility. Bieber AM; Marcon L; Hales BF; Robaire B J Androl; 2006; 27(2):189-200. PubMed ID: 16278370 [TBL] [Abstract][Full Text] [Related]
17. Developing an HPV vaccine to prevent cervical cancer and genital warts. Bryan JT Vaccine; 2007 Apr; 25(16):3001-6. PubMed ID: 17289220 [TBL] [Abstract][Full Text] [Related]
18. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Joura EA; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch X; Dillner J; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Lu S; Vuocolo S; Hesley TM; Haupt RM; Barr E Vaccine; 2008 Dec; 26(52):6844-51. PubMed ID: 18930097 [TBL] [Abstract][Full Text] [Related]
19. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine. Olsson SE; Villa LL; Costa RL; Petta CA; Andrade RP; Malm C; Iversen OE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E Vaccine; 2007 Jun; 25(26):4931-9. PubMed ID: 17499406 [TBL] [Abstract][Full Text] [Related]